Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas H Jones

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Case Reports|February 9, 2026
Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy-Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case ReportDouglas H Jones, Heidi Memmott
Journal of Food Allergy|July 18, 2024
Practical aspects of oral immunotherapy: The importance of optimal office design and workflowDouglas H Jones, Aerik Williams, Lisa Nguyen
The Journal of the American Osteopathic Association|May 7, 2004
Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndromeDouglas H Jones, Michael Todd, Timothy J Craig
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadineDouglas H Jones, Francisco A Romero, Thomas B Casale
The World Allergy Organization Journal|February 11, 2022
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitorDouglas H Jones, Priya Bansal, Jonathan A Bernstein, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 3, 2004
Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndromeDimitri G Trembath, Elena V Semina, Douglas H Jones, et al.
Allergy and Asthma Proceedings|December 27, 2023
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapyWilliam R Lumry, Jonathan A Bernstein, Henry H Li, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 25, 2024
The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksStephen D Betschel, Teresa Caballero, Douglas H Jones, et al.
The World Allergy Organization Journal|November 5, 2025
C1 esterase inhibitor (C1-INH) response as a supportive diagnostic criterion for patients with suspected hereditary angioedema with normal C1-INHAndrew M Smith, Henry J Kanarek, Jeffrey Rumbyrt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 16, 2024
Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral ImmunotherapyJordan Trevisonno, Carina Venter, Kaci Pickett-Nairne, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Case Reports|February 9, 2026
Managing Primary Immunodeficiency Immunoglobulin Replacement Therapy-Related Adverse Events With Recombinant Human C1 Esterase Inhibitor Prophylaxis: A Case ReportDouglas H Jones, Heidi Memmott
Journal of Food Allergy|July 18, 2024
Practical aspects of oral immunotherapy: The importance of optimal office design and workflowDouglas H Jones, Aerik Williams, Lisa Nguyen
The Journal of the American Osteopathic Association|May 7, 2004
Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndromeDouglas H Jones, Michael Todd, Timothy J Craig
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 4, 2008
Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadineDouglas H Jones, Francisco A Romero, Thomas B Casale
The World Allergy Organization Journal|February 11, 2022
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitorDouglas H Jones, Priya Bansal, Jonathan A Bernstein, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|March 3, 2004
Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndromeDimitri G Trembath, Elena V Semina, Douglas H Jones, et al.
Allergy and Asthma Proceedings|December 27, 2023
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapyWilliam R Lumry, Jonathan A Bernstein, Henry H Li, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 25, 2024
The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksStephen D Betschel, Teresa Caballero, Douglas H Jones, et al.
The World Allergy Organization Journal|November 5, 2025
C1 esterase inhibitor (C1-INH) response as a supportive diagnostic criterion for patients with suspected hereditary angioedema with normal C1-INHAndrew M Smith, Henry J Kanarek, Jeffrey Rumbyrt, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 16, 2024
Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral ImmunotherapyJordan Trevisonno, Carina Venter, Kaci Pickett-Nairne, et al.
Pageof 2